Citi raised the firm’s price target on GE HealthCare (GEHC) to $110 from $103 and keeps a Buy rating on the shares. Operating margins expanded ...

GE HealthCare Q4 earnings beat estimates with strong U.S. demand. 2025 outlook includes 2%-3% revenue growth and EPS guidance of $4.61-$4.75.

GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President an ...

GE HealthCare Technologies delivered solid fourth-quarter earnings, but domestic and international revenue growth remained ...

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) in Q4 CY2024, with sales up 2.2% year on year to $5.32 ...

Sees FY25 organic revenue growth of 2%-3% year-over-year, which reflects continued demand for products and services as well as a measured view ...

USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, Feb. 11, 2025 /PRNewswire/ -- USA News Group News Commentary - Weeks after the monumental ...

Beyond Stargate's big players, a growing number of innovators have been revolutionizing healthcare by making recent ...

Our calculations are based on comprehensive, delayed quotes. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all ...

1 Day GEHC -0.19% DJIA 0.06% S&P 500 -0.31% Health Care/Life Sciences 0.39% ...

The article continued: Recently Spotify's founder Daniel Ek's new HealthTech startup Neko Health secured a $260 million financing, valuing the company at approximately $1.8 billion. As part of the ...